Complications in Transplantation: Medication Nonadherence.

Area of Science:

• Transplant medicine
• Pharmacology
• Patient outcomes

Background:

• Solid organ transplant recipients require lifelong immunosuppressants to prevent rejection.
• Medication nonadherence rates post-transplant can be as high as 70%, negatively affecting graft survival and patient outcomes.
• Current adherence assessment methods lack a gold standard, hindering identification of at-risk populations.

Purpose of the Study:

• To review the challenges in assessing immunosuppressant adherence post-transplant.
• To highlight the critical link between medication adherence and patient outcomes.
• To propose future research directions for optimizing adherence monitoring and interventions.

Main Methods:

• Literature review of existing adherence assessment tools and their limitations.
• Analysis of the impact of nonadherence on transplant outcomes.
• Discussion of strategies for future research in adherence monitoring.

Main Results:

• No universally accepted gold standard exists for measuring immunosuppressant adherence.
• Nonadherence is a significant contributor to graft rejection, graft loss, and reduced patient survival.
• A clear link between adherence data, interventions, and clinical outcomes needs further investigation.

Conclusions:

• Immunosuppressant adherence cannot be assumed and requires proactive monitoring.
• Future studies should focus on developing surrogate markers for therapy adequacy.
• Investigating the association between adherence data, interventions, and outcomes is crucial for identifying effective strategies to improve transplant success.